WORK Medical Technology Group LTD
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $9.8M | $11.5M | $13.6M | $19.7M |
| Cost of Revenue | — | — | — | — |
| Gross Profit | $2.3M | $2.9M | $4.1M | $4.4M |
| Gross Margin | 23.8% | 24.9% | 30.5% | 22.4% |
| Operating Expenses | ||||
| Research & Development | $435.3K | $302.5K | $301.6K | $183.9K |
| SG&A Expense | $2.3M | $4.6M | $1.9M | $2.6M |
| Operating Income | $-578.5K | $-3.1M | $503.1K | $1.1M |
| Operating Margin | -5.9% | -27.0% | 3.7% | 5.6% |
| Interest Expense | $503.5K | $557.6K | $392.7K | — |
| Pretax Income | $-1.1M | $-3.7M | $110.4K | $1.1M |
| Income Tax Expense | $119.1K | $-125.3K | $47.0K | $169.4K |
| Net Income | $-1.1M | $-3.5M | $112.0K | $865.2K |
| Net Margin | -10.9% | -30.4% | 0.8% | 4.4% |
| EPS (Basic) | $-0.04 | $-0.14 | $0.01 | $0.04 |
| EPS (Diluted) | $-0.04 | $-0.14 | $0.01 | $0.04 |
| Shares Outstanding (Basic) | 29.0M | 25.4M | 25.0M | 25.0M |
| Shares Outstanding (Diluted) | 29.0M | 25.4M | 25.0M | 25.0M |
| Dividends Per Share | — | — | — | — |